Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease -- Ignore unavailable to you. Want to Upgrade?

To: Brian Moloney who wrote (2257)	3/31/1998 6:21:00 PM
From: ENOTS	Read Replies (2) \| Respond to of 3725

I wrote Imat and here is their response! and my response to their response....I feel we are in for trouble! MY RESPONSE +++++ READ THE BOTTOM LETTER FIRST< FOR PERSPECTIVE++++++ Lisa Kimberlin, Believe me, I am not threatening you! I just feel this is a delay that is holding back bad news! I have no feel for what it is, but have a gut feeling you are to report a downer for the year! I also feel that the stock price is going to tank, altho it cannot get much worse! I just love the technology, and thought it had great promise. I think your management needs assistance. Hire some firm to research a white knight, one with deep pockets that will properly market this product! Buy the firm out or merge! We are slowly sinking in my opinion! I have an appointment with my laywer on the 17th of April to discuss this sitituation. If indeed the report is ready at that time, I will be better informed as to the possibilities available to me and other stockholders. Thank you for your prompt response. I am still in the dark! C. W. Stone LK11 Imat wrote: THEIR REPLY Dear CW: I am sorry you feel it necessary to threaten the Company with a lawsuit. By filing for an extension with the SEC, we are by no means attempting to hide negative news. As I have relayed to investors, the Company did have difficulties in the fourth quarter with scanner sales to Asia due to the economic crises there. Asia represents a significant market for Imatron, and some scanner orders from Asian nations were cancelled or delayed. We expect to continue having difficulties selling scanners to Asia until the economic situation there improves. In addition, our HeartScan subsidiary, which we consolidate on a 100% basis, continues to experience losses. Even though we've seen our center results improve in response to new marketing strategies in the past few months, these centers are not at break even at this time. Since we changed our auditors from Ernst & Young to KPMG Peat Marwick, it has taken us longer to bring KPMG up to speed on our previous financial reporting. As you may know, Imatron has always taken the full 90 days at year end and full 45 days at quarter end to file financial reports with the SEC. In order to provide KPMG with the requested information to address their questions, we have experienced unanticipated delays, resulting in the filing extension. We expect to report our year end results within the 15 days. FYI, in the April 6, 1998, issue of Newsweek there is a favorable article on Imatron. The article is on page 72; this week's issue hits newsstands today. If I can be of further assistance, please do not hesitate to contact me. I hope this information is helpful to you. Regards, Lisa Kimberlin Imatron ++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ Additional thoughts....The earnings look like they will be non-existant...I look for a huge loss...I may be wrong, just my opinion!!!! I AM NOT HAPPY ABOUT THIS!!!!!!!!Sales cancelled in Asia, Heartscan still losing money, Accounting Questions, My daughter is a CPA with a large firm, she says, watch out!!!!!!

To: Brian Moloney who wrote (2257)	3/31/1998 7:17:00 PM
From: stock bull	Read Replies (1) \| Respond to of 3725

Hi Brian, good to hear from you. Sure would be nice to see IMAT take off. Both from a stock point of view, and the benefits to be gained through the early detection of CAD. I see that software has now been developed that allows for the "fly through" of the arteries. This now allows for the measurement of the blockages. I am posting the site for the company that developed the software. If you have the proper viewer, you can download and play a movie of the "fly through". As you move through the artery you will see the calcium and plaque buildup. A blockage of 98% is shown. The work on this video was done in conjunction with the University of California at San Francisco. Here's the link: accuimage.com Progress is coming, although very slowly. Stock Bull PS: Assuming that you can play the video, please let me know what you think of it.

To: Brian Moloney who wrote (2257)	4/1/1998 1:09:00 AM
From: Lee Kennedy	Read Replies (1) \| Respond to of 3725

<<I do have some good news. this week's Newsweek has a 2 column article with a headline and a picture on ultrafast CT and its advantages for screening for coronary disease. Imatron is not mentioned.>> Today should be the end of Imatron not being mentioned. I look forward to seeing the ultrafast CT displayed on television and in magazines with Imatron very visible to all viewers and readers. Also the Bristol Myers-Squibb radio ads should now include Imatron's name. Lee